Benefit Measures for ePMA. The benefits listed below are those that will be collected by the project team, some throughout the project and some at the end of full role out. The table shows the benefit to be measured and maps into the HSCIC submission as either a primary or secondary metric. The primary metrics are those which NHS Digital have accepted for the purpose of calculate the VfM. The secondary metrics are those which will be used if the primary metrics fail to meet the VfM. Benefit Theme Metric Reason Target Primary/Secondary (link to NHS Digital metric) Collection technique Responsibility Efficiency MDT views and opinions on multiple aspects of ePMA Gauge already held beliefs and anxieties about the system and then to see if those fears held true post implementation N/A N/A Pre/post survey monkey AY Safety Number of medication incidents within NTW To see if incidents decrease with ePMA. 50% reduction in IR2s related to prescribing & administration Secondary (NTW 10) Safer Medication Practice Group report MH to send to AY Safety Number of omissions in a month preceding go ‘live’ and then 3 months post go live To see if ePMA reduces un-coded omissions on medicines charts 0% (baseline 53%) Primary (NTW 1) RiO report (Reported as % number of charts per ward containing an omission) Project team Safety Number of charts with a missing allergy status To see if ePMA improves compliance with allergy recording 2% (baseline 4.5%) Primary (NTW 4) RiO report (Reported as % number of charts per ward not Project team
containing an allergy status) Efficiency Average time to complete the morning medication round (mins) + faxes and phonecalls etc To ascertain if ePMA decreases the amount of time required for medication tasks (band 5 nurse) Time in minutes per ward per month Primary (NTW 9) Pre/post implementation time in motion over two weeks Average time to fax/scan a kardex X average number per week/ward. Extrapolate as wards go live. Project team Clinical Number of antibiotic doses administered over the prescribed duration (using standard course lengths (IPC PGN 15) unless specified) Antibiotic stewardship Number of doses Secondary (NTW 12) Pre/post implementation check Clinical Pharmacy Team Clinical Number of patients prescribed HDAT POMH/RCPSych guidance. Also investigation of impact of sticker removal and active checking Number of patients Secondary (NTW 15) Pre/post implementation check Clinical Pharmacy Team Safety Accuracy of discharge letters post go ‘live’ Previous systems have a large degree of error. 0% of letters containing an error (baseline 67%) Primary (NTW 2) Post implementation check Clinical Pharmacy Team Safety Transcription error rates on rewriting kardexs Rewriting kardexs will not be required anymore once Zero rewrites will give a cost saving due to reduction in Secondary (NTW 13) Prior to roll out Project team
Trustwide rollout has been achieved ADRs (£1000 per reaction saved). Based on number of patients in hospital for over 3 months x error rate x 100. Error rate used is 7.8% (EQUIP, Protect, Lewis et al) Efficiency Doctor transcription time saved Rewriting kardexs will not be required anymore once Trustwide rollout has been achieved Zero rewrites will give a time saving. on number of patients in hospital over 3 months x avge number of items per kardex x average time to rewrite per item of 2 minutes Secondary (NTW 14) Prior to roll out Project team Safety Number of prescribed items not meeting NTW prescribing standards ePMA will improve the quality of prescribing 100% of prescriptions meet NTW standards Primary (NTW 3) Pre/post full Take 5 audit on each ward Clinical Pharmacy Team Financial Number of non medicines requested (non- continuation) The ePMA system will prompt users to use formulary medicines only A 50% reduction in requests (baseline of 14) Primary (NTW 7) Quarterly report Governance team Efficiency Variety of codes used on medicine A pull down list will make selection more diverse Numbers of each of the used only Pre/post Project team.
charts (omission/stop) Financial Trust medication spend The ePMA system will improve the efficiency of medication processes 5% decrease in annual medication spend Primary (NTW 5) Quarterly report Business admin team Financial Paper based charts cost ePMA will eradicate the need for the majority of paper medication charts £36k pa reduction in spend. (Baseline £40k pa) Primary (NTW 6) Quarterly report Business admin team Financial/Efficiency Dispensary transactions (all sites) The ePMA system will improve the efficiency of medication processes 5% reduction in costs. (Baseline £10 per item) Primary (NTW 8) Quarterly report Deputy Chief Pharmacist – Operational Services Safety Use of the allergy link within the system To ensure the workaround in place of SNOMED is a workable solution Number of clicks as a % of the number of prescriptions and administrations Trust only Post pilot review ePMA project team